Patents by Inventor Christopher KORTH

Christopher KORTH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-GALECTIN-9 ANTIBODIES AND THERAPEUTIC USES THEREOF
    Publication number: 20240190970
    Abstract: Disclosed herein are methods for treating solid tumors (e.g., pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), hepatocellular carcinoma (HCC), cholangiocarcinoma (CAA), renal cell carcinoma (RCC), urothelial, head and neck, breast cancer, lung cancer, or other gastrointestinal solid tumors), using an anti-Galectin-9) antibody, e.g., as a monotherapy or as a combined therapy with an immune checkpoint inhibitor.
    Type: Application
    Filed: April 29, 2022
    Publication date: June 13, 2024
    Applicant: PURETECH LYT, INC.
    Inventors: Aleksandra FILIPOVIC, Eric ELENKO, Heather PADEN, Christopher KORTH
  • COMBINATION OF ANTI-GALECTIN-9 ANTIBODIES AND CHEMOTHERAPEUTICS FOR USE IN CANCER THERAPY
    Publication number: 20240182583
    Abstract: Disclosed herein are combined therapies for treating solid tumors (e.g., pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC), hepatocellular carcinoma (HCC), cholangiocarcinoma (CAA), renal cell carcinoma (RCC), urothelial, head and neck, breast cancer, lung cancer, or other gastrointestinal solid tumors), comprising an antibody that binds human galectin-9 (anti-Gal9) antibody, e.g., G9.2-17), and one or more chemotherapeutics, for example, gemcitabine, paclitaxel, or a combination thereof.
    Type: Application
    Filed: April 29, 2022
    Publication date: June 6, 2024
    Applicant: PURETECH LYT, INC.
    Inventors: Aleksandra FILIPOVIC, Eric ELENKO, Heather PADEN, Christopher KORTH